Fierce Pharma

China’s National Medical Products Administration suspended the import, sale and [...]

Nearly two decades after the parties first floated the idea [...]

After posting 16.2% revenue growth in the last financial year, [...]

The companies had committed to a five-year partnership in July [...]

With Enhertu and Datroway, Daiichi Sankyo has made itself a [...]

Juggling a mix of customer demand and new regulations, Recipharm [...]

GLP-1 giant Eli Lilly has once again taken to the [...]

The new chairman of the CDC’s Advisory Committee on Immunization [...]

ST Pharm has struck a $56 million deal with an [...]

A potential inflection point that Bausch Health hoped could diversify [...]